Engineered particles as red blood cell mimics and compositions containing same for hematology
Inventors
Zhang, Daixuan • Kim, Jeffrey • Ahn, Keunho
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Provided herein are red blood cell control compositions containing one or more populations of lysable hydrogel particles having an impedance that is substantially similar to the impedance of a human red blood cell of average diameter; and a population of hemoglobin molecules or a population of dye molecules that have substantially similar absorbance as hemoglobin; wherein (i) and/or (ii) are present in an amount that corresponds to a normal blood sample or disease state, or (i) and (ii) are present at a ratio that corresponds to a normal blood sample or disease state.
Core Innovation
The invention describes a synthetic whole blood sample control comprising lysable hydrogel particles with impedance substantially similar to that of an average human red blood cell, hemoglobin molecules or dye molecules with absorbance substantially similar to hemoglobin, and non-lysable hydrogel particles with impedance substantially similar to that of an average human white blood cell. The lysable particles comprise a polymerized monomer and a bifunctional co-monomer containing a disulfide bond, an acid-labile bond, or both.
The control calibrates a hematology analyzer and evaluates a target whole blood sample by comparing red-blood-cell and white-blood-cell impedance measurements with corresponding particle populations. Particle size, porosity, polymer content, concentration, and hemoglobin or dye level are adjustable to model normal samples and conditions including microcytosis, macrocytosis, anisocytosis, anemia, and hyperchromia.
Claims Coverage
The claim coverage includes four inventive features across independent claims covering a synthetic whole blood sample control and methods for hematology analyzer calibration and whole blood sample evaluation.
Synthetic whole blood sample control
A synthetic whole blood sample control comprising lysable hydrogel particles with impedance substantially similar to an average human red blood cell, hemoglobin molecules and/or dye molecules with absorbance substantially similar to hemoglobin, and non-lysable hydrogel particles with impedance substantially similar to an average human white blood cell, wherein the lysable particles comprise a polymerized monomer and a bifunctional co-monomer containing a disulfide bond, an acid-labile bond, or a combination thereof.
Hematology analyzer calibration
A method of calibrating a hematology analyzer using the synthetic whole blood sample control by measuring impedance of lysable hydrogel particles to calibrate red-blood-cell analysis, lysing the lysable particles using a buffer corresponding to a disulfide bond or an acid-labile bond, and calibrating white-blood-cell analysis based on impedance measured from non-lysable hydrogel particles.
Whole blood sample impedance evaluation
A method of evaluating a target whole blood sample by measuring impedance of red blood cells and white blood cells and comparing those measurements with the impedance of corresponding lysable and non-lysable hydrogel particle populations in a synthetic whole blood control, wherein the lysable particles comprise a polymerized monomer and a bifunctional co-monomer containing a disulfide bond, an acid-labile bond, or both.
Whole blood sample evaluation with particle lysis
A method of evaluating a target whole blood sample by comparing red- and white-blood-cell impedance measurements with corresponding particle populations in a synthetic whole blood control and measuring non-lysable particle impedance after lysing the lysable hydrogel particles using a lysis buffer, specifying a disulfide bond with a reducing-agent buffer or an acid-labile bond with formic acid.
The independent claims cover the synthetic control composition, analyzer calibration using the control, and two methods for evaluating target whole blood samples through impedance comparisons with lysable and non-lysable hydrogel particle populations.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Calibration of a hematology analyzer for analysis of red blood cells and white blood cells in a target whole blood sample.
Evaluation of a target whole blood sample by comparing red-blood-cell and white-blood-cell impedance with corresponding hydrogel particle impedance in a synthetic whole blood control.
Adjustment of control properties to model normal samples and conditions including microcytosis, macrocytosis, anisocytosis, anemia, and hyperchromia.
Interested in licensing this patent?